| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 06/05/2002 | EP0815134B1 Modulators of amyloid aggregation |
| 06/05/2002 | EP0813420B1 Treatment of cerebral ischemia and cerebral damage with neuroprotective agent |
| 06/05/2002 | EP0804228B1 Medicament containing protein C activation peptide |
| 06/05/2002 | EP0804182B1 Use of gabapentin in the treatment of anxiety and panic |
| 06/05/2002 | EP0788501B1 Protein kinase inhibitors for treatment of neurological disorders |
| 06/05/2002 | EP0724637B2 Corticotropin-releasing factor 2 receptors |
| 06/05/2002 | EP0722319B1 Anthracyclinone derivatives and their use in amyloidosis |
| 06/05/2002 | EP0711282B1 Compounds as pde iv and tnf inhibitors |
| 06/05/2002 | EP0629199B1 Indole derivatives as 5-ht1 agonists |
| 06/05/2002 | CN1352694A Novel system for regulating transgene expression |
| 06/05/2002 | CN1352651A Method for inhibiting macrophage infiltration using monoconal anti-alpha-D-antibodies |
| 06/05/2002 | CN1352650A Recombinant IL-18 antagonist useful in treatment of IL-18 mediated disorders |
| 06/05/2002 | CN1352644A I-amino triazolo [4,3-alpha] quinazoline -5-ones and/or -5-thiones inhibiting phosphodiesterase IV |
| 06/05/2002 | CN1352638A Novel polyhydroxypyrazine derivatives, preparation and pharmaceutical compositions containing same |
| 06/05/2002 | CN1352631A Aromatic amides |
| 06/05/2002 | CN1352568A Water soluble compositions for bioactive lipophilic compounds |
| 06/05/2002 | CN1352564A Pharmaceutical composition containing elegiline and ginkgo bioloba extract useful for dementia |
| 06/05/2002 | CN1352562A Copper agonist that binds on the copper binding site of APP and/or exerts an inhibiting effect on the release of anyloid A beta peptide |
| 06/05/2002 | CN1352560A Ziprasidone suspension |
| 06/05/2002 | CN1352556A Therapeutic use of melatonin |
| 06/05/2002 | CN1352555A Use of anticonvulsant derivatives for treating cluster headaches |
| 06/05/2002 | CN1352554A IL-8 receptor antagaonists |
| 06/05/2002 | CN1352549A Methods and devices for providing prolonged drug therapy |
| 06/05/2002 | CN1352545A 吲哚衍生物 Indole derivatives |
| 06/05/2002 | CN1085981C Nicotinic acid ester compounds and its salts, their preparation and medicine composition containing them |
| 06/05/2002 | CN1085980C Meta-guanidine, urea, thiourea or azacyclic amino benzoic and derivatives as integrin antagaonists |
| 06/05/2002 | CA2364211A1 Combination treatment for depression, anxiety and psychosis |
| 06/04/2002 | USRE37729 Useful as antipsychotic and analgesic agents. |
| 06/04/2002 | US6399826 Salts of sibutramine metabolites, methods of making sibutramine metabolites and intermediates useful in the same, and methods of treating pain |
| 06/04/2002 | US6399797 Vitamin D analogues |
| 06/04/2002 | US6399780 Kinase inhibitors; anticancer agents |
| 06/04/2002 | US6399762 Methods and compositions for diagnosing and treating chromosome -18p related disorders |
| 06/04/2002 | US6399656 Using a benzopyran-3-carboxamide compound |
| 06/04/2002 | US6399653 Ring fused dihydropyrans, process for preparation and use thereof |
| 06/04/2002 | US6399650 Improving the disturbances of the activities of daily living (adl) in a post-stroke patients comprises administering to the patient an effective amount of nefiracetam within the first six months after the stroke |
| 06/04/2002 | US6399648 N-oxides of heterocyclic ester, amide, thioester, or ketone for vision and memory disorders |
| 06/04/2002 | US6399643 Spiroimidazolidine derivatives, their preparation, their use and pharmaceutical preparations formed therefrom |
| 06/04/2002 | US6399641 For therapy and prophylaxis of psychosis, schizophrenia, alzheimer's disease, cognitive disorders and restricted brain function caused by bypass operations or transplants, poor blood supply to the brain, spinal cord injuries etc. |
| 06/04/2002 | US6399636 For therapy of asthma, chronic bronchitis, chronic obstructive pulmonary disease (copd), eosinophilic granuloma, psoriasis and septic shock, ulcerative colitis, crohn's disease, reperfusion injury of the myocardium and brain |
| 06/04/2002 | US6399635 N,n-diethyl-4-(n-piperidin-3-yl-anilino) benzamide compound; reductive amination of a 3-piperidone, arylation |
| 06/04/2002 | US6399626 Useful in inducing immunosuppression and in treatment of transplantation rejection, autoimmune diseases, solid tumors, fungal infections, vascular disease |
| 06/04/2002 | US6399616 4-(4-(2-(5-(1,2,4-triazol-1-ylmethyl)-1h-indol-3-yl)ethyl)-1 -piperazinyl)furo(3,2-c)pyridine; combined serotonin reuptake inhibitor and partial agonist of 5-ht receptors; reduced latency; depression |
| 06/04/2002 | US6399609 Corticotropin releasing factor (crf) antagonists |
| 06/04/2002 | US6399608 Fluoxetine, paroxetine or sertraline with 1,2,4-triazolo (4,3-b)pyridazine derivative; nonsedating anxiolytic modulator of benzodiazepine binding site of gamma amino-butyric acid receptor; central nervous system |
| 06/04/2002 | US6399606 3-(((2r)-2-(((2-fluorophenyl)amino)carbonylamino)-2-(methoxy carbonyl)ethylthio)methyl)-4-oxo-4-(3-pyridyl)butanoic acid; treatment of chemotherapy induced neuropathy |
| 06/04/2002 | US6399603 Therapeutic heterocycles |
| 06/04/2002 | US6399577 Central nervous system disorders |
| 06/04/2002 | US6399576 Administering dosage of batroxobin |
| 06/04/2002 | US6399384 Conditional immortalization of cells |
| 06/04/2002 | US6399314 Methods of detection of amyloidogenic proteins |
| 06/04/2002 | US6399312 Myostatin gene promoter and inhibition of activation thereof |
| 06/04/2002 | US6399079 Spill resistant pharmaceutical compositions in semi-solid form |
| 06/04/2002 | US6399072 Reverse addiction with isoflavones, lignans, sapoins, catechins and phenol acids |
| 06/04/2002 | CA2364108A1 Acylamino cyclopropane derivatives |
| 06/04/2002 | CA2302396C Allosteric adenosine receptor modulators |
| 06/04/2002 | CA2248366C Quinoxalinediones |
| 06/04/2002 | CA2067929C Piperazine derivatives |
| 05/30/2002 | WO2002042462A2 Therapeutic agents and methods of use thereof for treating an amyloidogenic disease |
| 05/30/2002 | WO2002042455A2 Modifier of organelle metalbolism |
| 05/30/2002 | WO2002042454A2 Gene involved in schizophrenia |
| 05/30/2002 | WO2002042437A2 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof |
| 05/30/2002 | WO2002042429A2 Methods of isolating amyloid-inhibiting compounds and use of compounds isolated from uncaria tomentosa and related plants |
| 05/30/2002 | WO2002042332A2 Truncated cd200 |
| 05/30/2002 | WO2002042330A2 Cystoskeleton-associated proteins |
| 05/30/2002 | WO2002042309A1 Indole derivatives and use thereof in medicines |
| 05/30/2002 | WO2002042306A1 Benzimidazole derivatives, preparation and therapeutic use thereof |
| 05/30/2002 | WO2002042302A1 Novel sulfonamide-substituted pyrazolopyridine derivatives |
| 05/30/2002 | WO2002042301A1 Novel pyridine-substituted pyrazolopyridine derivatives |
| 05/30/2002 | WO2002042300A1 Novel carbamate-substituted pyrazolopyridine derivatives |
| 05/30/2002 | WO2002042299A1 Novel lactame-substituted pyrazolopyridine derivatives |
| 05/30/2002 | WO2002042298A1 Aminothiazoles and their use as adenosine receptor antagonists |
| 05/30/2002 | WO2002042297A1 Piperidine compounds and medicinal use thereof |
| 05/30/2002 | WO2002042296A1 Farnesyl transferase inhibiting benzoheterocyclic derivatives |
| 05/30/2002 | WO2002042293A1 Isoquinoline derivatives useful in the treatment of cns disorders |
| 05/30/2002 | WO2002042292A2 Indol derivative and their use as inhibitors of p38 kinase |
| 05/30/2002 | WO2002042280A2 Pyrimidine derivatives |
| 05/30/2002 | WO2002042278A2 Imidazole and benzimidazole caspase inhibitors and uses thereof |
| 05/30/2002 | WO2002042273A2 Acid derivatives useful as serine protease inhibitors |
| 05/30/2002 | WO2002042269A1 3-arylindole derivatives and their use as cb2 receptor agonists |
| 05/30/2002 | WO2002042257A1 Substituted cyclohexane derivates and the use thereof in medicaments for treating cardiovascular diseases |
| 05/30/2002 | WO2002042256A2 N-alkylated gaba compounds, processes for their preparation and their use as medicaments |
| 05/30/2002 | WO2002042250A1 DERIVATIVES OF 4-HYDROXYBUTANOIC ACID AND OF ITS HIGHER HOMOLOGUE AS LIGANDS OF η-HYDROXYBUTYRATE (GHB) RECEPTORS, PHARMACEUTICAL COMPOSITIONS CONTAINING SAME AND PHARMACEUTICAL USES |
| 05/30/2002 | WO2002042248A2 Naphthalene derivatives |
| 05/30/2002 | WO2002041915A1 A composition of sodium channel blocking compound |
| 05/30/2002 | WO2002041893A1 Therapy for herpes neurological viral conditions utilizing 1,4-dihydropyridine calcium channel blockers |
| 05/30/2002 | WO2002041889A2 Indolsulfonyl compounds useful in the treatment of cns disorders |
| 05/30/2002 | WO2002041884A2 Inhibitors of abc drug transporters at the blood-brain barrier |
| 05/30/2002 | WO2002041882A2 Combination comprising an agent decreasing vegf activity and an agent decreasing egf activity |
| 05/30/2002 | WO2002041881A2 Repinotan kit |
| 05/30/2002 | WO2002041878A2 Titratable dosage transdermal delivery system |
| 05/30/2002 | WO2002041842A2 Antibody pti-hs7 for treatment of alzheimer's disease and other amyloidoses and parkinson's disease |
| 05/30/2002 | WO2002041839A2 Assays for inhibitors of neuronal transport of alzheimer's amyloid precursor protein |
| 05/30/2002 | WO2002041691A2 Transgenic or recombinant non-human mammals and their uses in screening psycho-active medicines |
| 05/30/2002 | WO2002028440B1 Methods and compositions for modulating t cell activation and uses thereof |
| 05/30/2002 | WO2002020736A9 Proteases |
| 05/30/2002 | WO2002018581A9 G-protein coupled receptors |
| 05/30/2002 | WO2002017358A3 Quinuclidine-substituted heteroaryl moieties for treatment of disease (nicotinic acetylcholine receptor antagonists) |
| 05/30/2002 | WO2002016357A3 Quinuclidine-substituted aryl moieties for treatment of disease (nicotinic acetylcholine receptor ligands) |
| 05/30/2002 | WO2002016333A3 Thioflavin derivatives and their use in diagnosis and theraphy of alzheimer's disease |
| 05/30/2002 | WO2002013805A3 Method of treating neurodegenerative disorders of the retina and optic nerve head |